Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) reported Q4 EPS of ($0.53), $0.05 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $1.98 million versus the consensus estimate of $941.92 thousand.

For earnings history and earnings-related data on Verrica Pharmaceuticals Inc. (VRCA) click here.